SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike M who wrote (1055)10/15/1999 4:00:00 PM
From: DanZ  Read Replies (1) of 5582
 
Mike,

I'm with you. I also bought some more at 12 7/16 and 12 7/8 a few minutes ago and it's locked away with the rest of my position. It's strange how we got filled at exactly the same prices LOL. I like the base that has formed at 12 1/2 and the way the stock has bounced strongly with very little size on the offer whenever it gets there. There are few sellers and you're right about how small the trading float has become. The demand for the stock is also evident on Level II on the bid. I also had an order in to buy some at 12 3/8 that didn't get filled.

You'd have to be totally nuts to be short this stock right now. The risk to reward is atrocious. We have a couple of points of downside if Zicam completely flops and God knows how high the stock will trade if they can claim that Zicam prevents the common cold. If the clinical study for prevention comes back conclusive that Zicam prevents the common cold, this stock could easily trade to 40, 50, ? in one day. The risk to reward is better than 20 to 1 in my estimation. It makes absoultely no sense to be short.

Luck everyone,

Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext